Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
L'Alliance européenne des Stablecoins nomme un ancien dirigeant de Coinbase au poste de directeur général
Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, a déposé 23 000 ETH au CEX au cours de la semaine écoulée
La Banque centrale de Russie a confirmé qu'elle pourrait assouplir les règles de régulation des cryptomonnaies.
OCDE: S’attend à ce que la Réserve fédérale "abaisse progressivement" le taux directeur à 3,25% à 3,5%
Le géant de la gestion des actifs Tidal Investments acquiert environ 60 millions de dollars en actions stratégiques
Assistance client:@weikecs
Collaborations commerciales:@weikecs
Trading quantitatif/Market makers:[email protected]
Programme VIP:[email protected]